"hard to raise it in the present circumstances for any company let alone a microcap. I know it’s very difficult as someone who is trying to get financing in the current market." - are you kidding? In my opinion, this is completely wrong.
The market is flush with cash at the moment, particularly in the US and Europe, with PE firms throwing their money at any SME firms which have a reasonable chance of success. Investors and investment firms, are hesitant to keep their cash holdings high in such a high-inflation rate environment, where their capital is losing between 3-7% per annum in value.
If CDX has such a great product offering, and is so close to multi-bagging due to its product launch, then finding financing would have not been an issue.
Add to My Watchlist
What is My Watchlist?
